L. Bratescu

发表

A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt

D. Majumdar, C. Beattie, A. Shilkaitis, 2011, Angiogenesis.

p28, A first in class peptide inhibitor of cop1 binding to p53

S. Cannistraro, C. Beattie, A. Bizzarri, 2013, British Journal of Cancer.

Bexarotene Induces Cellular Senescence in MMTV-Neu Mouse Model of Mammary Carcinogenesis

A. Shilkaitis, K. Christov, Tohru Yamada, 2013, Cancer Prevention Research.

Retinoids suppress premalignant MCF10AT but not malignant MCF10CA1a breast epithelial cells in vivo. Role of retinoic acid receptor beta2 expression.

A. Shilkaitis, Xinjian Peng, K. Christov, 2005, Cancer letters.

Chromosome abnormalities in metastatic melanoma

S. Rauth, L. Bratescu, A. Green, 1994, In Vitro Cellular & Developmental Biology - Animal.

In vitro transformation of human congenital naevus to malignant melanoma

A. Shilkaitis, R. Mehta, R. Mehta, 2002, Melanoma research.

Early in vitro passages of breast cancer cells are differentially susceptible to retinoids and differentially express RARβ isoforms.

A. Shilkaitis, Xinjian Peng, K. Christov, 2011, International journal of oncology.

Noncationic peptides obtained from azurin preferentially enter cancer cells.

C. Beattie, A. Chakrabarty, A. Shilkaitis, 2009, Cancer research.

Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent

J. Pezzuto, G. Salti, J. Kichina, 2001, Melanoma research.

Establishment and characterization of four Sinclair swine cutaneous malignant melanoma cell lines.

C. Beattie, A. Green, A. Shilkaitis, 1992, Cancer genetics and cytogenetics.

Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice.

S. Rauth, A. Green, J. Kichina, 1994, Anticancer research.

A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells

D. Majumdar, C. Beattie, A. Shilkaitis, 2009, Molecular Cancer Therapeutics.

Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity

A. Chakrabarty, A. Fialho, V. Punj, 2005, Cellular microbiology.

Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization.

C. Beattie, A. Shilkaitis, R. Mehta, 1992, Anticancer research.

Differentiation of human breast carcinoma cells by a novel vitamin D analog: 1alpha-hydroxyvitamin D5.

R. Mehta, R. Mehta, L. Bratescu, 2000, International journal of oncology.